IP Library › Patent Application 15883006
Patent Application
App. No. 15/883,006

NOVEL IMMUNOGLOBULIN VARIANTS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/883,006
Abstract

The present invention relates to Fc variants with optimized Fc ligand binding properties, methods for their generation, Fc polypeptides comprising Fc variants with optimized Fc ligand binding properties, and methods for using same.

Claims (7)

1 - 15 . (canceled)

16 . An antibody having specificity for HIV gp120, said antibody comprising an Fc variant of a human IgG1 Fc polypeptide, wherein said Fc variant comprises amino acid modifications S239D, A330L, and I332E in the Fc region of said human IgG1 Fc polypeptide, wherein numbering is according to the EU index.

17 . A nucleic acid encoding an antibody according to claim 16 .

18 . An expression vector comprising the nucleic acid according to claim 17 .

19 . A host cell comprising the expression vector according to claim 18 .

20 . A method of making an antibody, said method comprising culturing a host cell according to claim 19 under conditions appropriate for expression of the antibody.

21 . A method of treating a patient having human immunodeficiency virus (HIV) comprising administering to said patient a composition comprising an antibody according to claim 1 .